Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 20198 results available
- November 20193 results available
- October 20197 results available
- September 20196 results available
- August 20191 results available
- July 20199 results available
- June 20197 results available
- May 20199 results available
- April 20198 results available
- March 20195 results available
- February 20193 results available
- January 20193 results available
Displaying 1 - 15 of 69 items.
GILENYA (fingolimod) - Risk of Congenital Malformations
AlertHealth professional risk communication | 2019-12-19
Alcohol, Cannabis and Drug Use During the Holiday Season
AlertInformation update | 2019-12-17
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
AlertHealth professional risk communication | 2019-12-02
Unauthorized products may pose serious health risks (October 2, 2019 to November 19, 2019)
AlertPublic advisory | 2019-11-19
ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes
AlertHealth professional risk communication | 2019-11-04
Unauthorized soft-shelled hyperbaric chambers may pose serious health risks
AlertInformation update | 2019-10-25
Foreign Product Alert: 24 foreign health products found to contain undeclared drug ingredients
AlertForeign product alert | 2019-10-18
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
AlertHealth professional risk communication | 2019-10-15